Prescription thyroid drug recalled due to temperature storage deviation
ARMOUR THYROID 120 mg tablets in batch W05543 are being recalled nationwide due to exposure to temperatures outside the labeled storage conditions. No illnesses or injuries have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall due to storage temperature deviation, but no illnesses or injuries reported. The hazard is precautionary in nature—a potential loss of product stability from improper storage—rather than confirmed contamination or documented harm.
Plain-English summary
ARMOUR THYROID (thyroid, porcine), 2 grain (120 mg) tablets in batch W05543 are being recalled nationwide by Cardinal Healthcare due to current good manufacturing practice (CGMP) deviations. The product was exposed to temperatures outside of the manufacturer's labeled storage conditions during distribution.
The FDA has classified this as a Class II recall. Proper storage conditions for prescription medications are essential to maintain product integrity.
Patients taking ARMOUR THYROID from batch W05543 (NDC 0456-0461-01) should contact their pharmacist or healthcare provider to verify whether their medication is from the recalled batch. Patients should consult their healthcare provider before making any changes to their thyroid medication. No illnesses or injuries have been reported in connection with this recall.
The recalled product
- Product
- ARMOUR THYROID (THYROID, PORCINE)
- Brand
- ARMOUR THYROID
- Manufacturer
- CARDINAL HEALTHCARE
- Hazard
- temperature-excursion
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch W05543
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27